Arterial hypertension treatment changes in Yaroslavl region: results obtained after 4 years of complex program of regional healthcare system’s improvement implementation

Program’s aim. Cardiovascular morbidity and mortality rates in Russia are among the highest in Europe. The aim of this work was to implement a complex healthcare system improvement program in Russia’s Yaroslavl region, dedicated to increasing arterial hypertension treatment efficacy and prevent complications of arterial hypertension. Materials and methods. The program was developed by a group of healthcare professionals of the Department of Healthcare and Pharmacy of Yaroslavl region together with Novartis Pharma Company’s technical advice within the framework of a private-public partnership. The program consisted of several actions aiming to raise the healthcare system’s attention to hypertension. Achievement of target blood pressure (BP) control by every patient seen by physicians of the Yaroslavl region healthcare system became the main goal and leading criteria for assessing hypertension treatment efficacy. Additionally, significant effort was put into patient education on self-control of BP levels and importance of achieving target BP levels in accordance with Russian national clinical guidelines and on adherence to treatment. Within 4 years, program efficacy was evaluated and reinforced by conducting annual cross-sectional questionnaire-based epidemiological studies. Analysis was performed in a representative sample of patients that evaluated BP control level, mean BP levels, systolic BP level distribution by grades, as well as cardiovascular risk factors and concomitant diseases presence and current antihypertensive therapy. In addition, analysis of official statistics on disease incidence and drug sales databases were performed. Results. From 2011 to 2014 BP control level increased significantly: 17% of patients had BP<140/90 mm Hg in 2011, 23% in 2012, 32% in 2013 and 33% in 2014. In the same time mean BP level reduced from 151/90 to 145/86 mm Hg and share of patients with systolic BP≥180 mm Hg decreased from 10% to 5%. Stroke incidence declined by 20% (from 4,6 to 3,7 per 1000 adult population in 2011 and 2014 respectively) and antihypertensive drug utilization increased by 16% (2014 vs. 2011). Conclusion. A healthcare system improvement program aiming to increase hypertension treatment efficacy resulted in significant improvement in BP control level and substantial decrease in stroke incidence. Continuous improvement is necessary to increase BP control level further resulting in reduction of cardio-vascular mortality and morbidity in the region. Nationwide system for hypertension drug provision could be an instrument of further improvement.

hypertension, blood pressure control level, russian guidelines

1. Nichols M, Townsend N, Luengo-Fernandez R et al. European cardiovascular disease statistics 2012. European Heart Network, Brussels, European Society of Cardiology, Sophia Antipolis 2012; https://www.escardio.org/static_file/Escardio/Press-media/press-releases/2013/EU-cardiovascular-disease-statistics-2012.pdf. Accessed February 11, 2016.

2. Росстат. Здравоохранение. 2015.

3. Диагностика и лечение артериальной гипертензии (Рекомендации Российского медицинского общества по артериальной гипертонии и Всероссийского научного общества кардиологов) // Системные гипертензии. 2010; 7 (3): 5-26.

4. Mozheyko M, Eregin S, Vigdorchik A, Hughes D. A cross - sectional survey of hypertension diagnosis and treatment practices among physicians in Yaroslavl Region, Russia. Adv Ther 2012; 29 (12): 1016-25.

5. Mozheyko M, Eregin S, Vigdorchik A et al. Changes in hypertension treatment in the Yaroslavl region of Russia: improvements observed between 2 cross - sectional surveys. J Clin Hypertens (Greenwich) 2013; 15 (12): 918-924.

6. Можейко М.Е., Ерегин С.Я., Вигдорчик А.В. и др. Изменения в лечении артериальной гипертонии в Ярославской области: промежуточные результаты годовой реализации комплексной программы по модернизации областной системы здравоохранения // Системные гипертензии. 2014; 11 (4): 30-6.

7. Mozheyko M, Eregin S, Danilenko N et al. Hypertension in Russia: Changes Observed After 4 Years of a Comprehensive Health System Improvement Program in the Yaroslavl Region. J Clin Hypertens (Greenwich) 2016. DOI: 10.1111/jch.12885.

8. Заболеваемость взрослого населения России в 2014 году. Статистические материалы. Часть III. М.: ФГБУ «Центральный научно - исследовательский институт организации и информатизации здравоохранения» Минздрава России, 2015.

9. Заболеваемость взрослого населения России в 2012 году. Статистические материалы. Часть III. М.: ФГБУ «Центральный научно - исследовательский институт организации и информатизации здравоохранения» Минздрава России, 2013.

10. www.imshealth.com [in Russian]

11. Campbell N.R, Niebylski M.L, World Hypertension League Executive. Prevention and control of hypertension: developing a global agenda. Curr Opin Cardiol 2014; 29 (4): 324-30.

12. Campbell N.R, Tu K, Brant R et al. Canadian Hypertension Education Program Outcomes Research Task Force. The impact of the Canadian Hypertension Education Program on antihypertensive prescribing trends. Hypertension 2006; 47 (1): 22-8.

13. Tu J.V, Nardi L, Fang J et al. National trends in rates of death and hospital admissions related to acute myocardial infarction, heart failure and stroke, 1994-2004. CMAJ 2009; 180 (13): E118-E125.

14. Jaffe M.G, Lee G.A, Young J.D et al. Improved blood pressure control associated with a large - scale hypertension program. JAMA 2013; 310 (7): 699-705.

15. Sillah A, Sidebottom A.C, Boucher J.L et al. Program participation and blood pressure improvement in the Heart of New Ulm Project, Minnesota, 2009-2011. Prev Chronic Dis 2014; 11: E48.

16. Falaschetti E, Chaudhury M, Mindell J, Poulter N. Continued improvement in hypertension management in England: results from the Health Survey for England 2006. Hypertension 2009; 53 (3): 480-6.

17. Nissinen A, Kastarinen M, Tuomilehto J. Community control of hypertension - experiences from Finland. J Hum Hypertens 2004; 18 (8): 553-6.

18. Chen X.J, Gao X.L, You G.Y et al. Higher blood pressure control rate in a real life management program provided by the community health service center in China. BMC Public Health 2014; 14: 801.

19. Ощепкова Е.В. О ходе реализации федеральной целевой программы «Профилактика и лечение артериальной гипертонии в Российской Федерации». http://federalbook.ru/files/FSZ/soderghanie/Tom%206/XIII/Oschepkova.pdf.

20. Campbell N.R, Brant R, Johansen H et al. Increases in antihypertensive prescriptions and reductions in cardiovascular events in Canada. Hypertension 2009; 53 (2): 128-34.

21. Mc Alister F, Wilkins K, Joffres M et al. Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades. CMAJ 2011; 183 (9): 1007-13.

22. Padwal R.S, Bienek A, Mc Alister F.A, Campbell N.R, Outcomes Research Task Force of the Canadian Hypertension Education Program. Epidemiology of hypertension in Canada: an update. Can J Cardiol 2016; 32 (5): 687-94.

23. Trusko B, Pexton C, Harrington J, Gupta P.K. Improving Healthcare Quality and Cost with Six Sigma. Upper Saddle River, NJ: FT Press; 2007.

24. Аналитический отчет. Фармацевтический рынок России. DSM Group. 2014. http://www.dsm.ru

25. Health at a Glance 2015, OECD Indicators. DOI: 10.1787/health_glance-2015-en. Собственный анализ статистических материалов авторами.

26. SPRINT Research Group, Wright J.T Jr, Williamson J.D et al. A randomized trial of intensive versus standard blood - pressure control. N Engl J Med 2015; 373 (22): 2103-16.

27. Shum K, Alperin P, Shalnova S et al. Simulating the impact of improved cardiovascular risk interventions on clinical and economic outcomes in Russia. PLoS One 2014; 9 (8): e103280.